Nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease is a clinicopathologic syndrome that encompasses several clinical entities. The spectrum of conditions ranges from simple steatosis to steatohepatitis, fibrosis and end stage liver disease. The condition was originally described in obese, diabetic, middle-aged female...

Full description

Bibliographic Details
Published in:	Annals of Hepatology
Main Authors:	Lafaine M. Grant, Mauricio Lisker-Melman
Format:	Article
Language:	English
Published:	Elsevier 2004-07-01
Subjects:	Nonalcoholic steatohepatitis liver obesity fatty liver
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119321003

Similar Items

Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
by: Maria Sotiropoulou, et al.
Published: (2021-01-01)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
by: Ho Soo Chun, et al.
Published: (2023-04-01)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Ji-Young Cha, et al.
Published: (2018-12-01)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
by: Ekaterina E. Mishina, et al.
Published: (2017-12-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
by: Karima Begriche, et al.
Published: (2023-01-01)

Bariatric surgery and nonalcoholic fatty liver disease: current and potential future treatments
by: Akira eSasaki, et al.
Published: (2014-10-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Recent Epidemiology of Nonalcoholic Fatty Liver Disease
by: Soumya Murag, et al.
Published: (2021-03-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
by: Apollinariya V. Bogolyubova, et al.
Published: (2017-12-01)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
by: Lucia Carulli, et al.
Published: (2019-02-01)

A review of nonalcoholic fatty liver disease - genetics and animal models
by: Ze Zheng, et al.
Published: (2016-01-01)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2022-09-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis
by: Mohamed Salaheldin, et al.
Published: (2023-08-01)

Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy
by: Reeju Amatya, et al.
Published: (2023-07-01)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
by: Georgiana-Emmanuela Gîlcă-Blanariu, et al.
Published: (2023-10-01)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
by: Bing Yang, et al.
Published: (2023-09-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD)
by: Narendra S. Choudhary, et al.
Published: (2012-07-01)

The use of very low‐calorie diets in subjects with obesity complicated with nonalcoholic fatty liver disease: A scoping review
by: Grant J. Herrington, et al.
Published: (2022-08-01)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
by: Alexandra C. Finney, et al.
Published: (2023-05-01)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
by: Chanbin Lee, et al.
Published: (2019-10-01)

Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis
by: Tingting Kong, et al.
Published: (2023-10-01)

Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
by: Wasitha P. D. W. Thilakarathna, et al.
Published: (2024-02-01)

Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview
by: Asad Dajani, et al.
Published: (2016-01-01)

Prevalence of Fatty Liver Disease in Obese Children and Adolescents Who Referred to Pediatric Clinic of Kashan University of Medical Sciences, Iran (2012-2013)
by: K Shiasi Arani, et al.
Published: (2013-09-01)

Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Panagiotis Theofilis, et al.
Published: (2022-05-01)

Nonalcoholic fatty liver disease: A risk factor for chronic kidney disease
by: Kellyane Dias Carvalho, et al.
Published: (2023-09-01)

Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
by: Yoshihisa Takahashi, et al.
Published: (2023-01-01)

Nonalcoholic fatty liver disease associated with obesity and type 2 diabetes and gut dysbiosis
by: T.M. Bentsa
Published: (2024-04-01)

Gallstone Disease Does Not Predict Liver Histology in Nonalcoholic Fatty Liver Disease
Published: (2014-05-01)

Association of insulin resistance and non-alcoholic fatty liver disease
by: Ekaterina E. Mishina, et al.
Published: (2021-01-01)

Mechanisms of ferroptosis in nonalcoholic fatty liver disease and therapeutic effects of traditional Chinese medicine: a review
by: Nan Wang, et al.
Published: (2024-03-01)

Association between gastroesophageal reflux disease and nonalcoholic fatty liver disease: A meta-analysis
by: Karn Wijarnpreecha, et al.
Published: (2017-01-01)

Features of Glucose Homeostasis and Blood Lipid Spectrum in Patients with Nonalcoholic Fatty Liver Dis ease Depending on the Obesity Degree
by: Korniichuk I., et al.
Published: (2019-04-01)

SYSTEMATIC REVIEW WITH COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
by: N.A. TOKTOGULOVA
Published: (2021-03-01)

Locoregional Therapies for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Stephen Susman, et al.
Published: (2024-09-01)

Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations
by: CM Oneta
Published: (2002-09-01)